{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:29:09Z","timestamp":1787729349074,"version":"build-2784847793"},"reference-count":35,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2017,6,19]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Patients with clinical, genetic and histological features of coeliac disease (CD), but negative for serological markers, pose a significant clinical problem. The aim of this study was to outline a specific profile, and to evaluate the natural history and response to gluten-free diet (GFD) of patients with seronegative CD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                     <jats:sc>p<\/jats:sc>atients with duodenal mucosa damage Marsh I, II and III stages, HLA DQ2\/DQ8 haplotype and clinical features suggestive of CD, but negative for CD serology, were defined as seronegative CD patients. Other common causes of duodenal mucosa damage were excluded. HLA\u2013DR and DQ genotype\/haplotype between all Marsh stages of patients with seronegative and seropositive CD were compared. Clinical features, laboratory testing and histological findings were evaluated after a GFD and a gluten rechallenge. A long follow-up period was available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>48 patients fulfilled diagnostic criteria over a 4-year period. Clinical phenotype and HLA\u2212DR and DQ frequencies between patients with seronegative and seropositive CD was similar. However, Marsh I stage was more prevalent in seronegative patients (42% vs 22%; p&lt;0.05). After a 1-year GFD trial, clinical symptoms, histological features and laboratory testing improved in 40 patients and worsened in those who underwent a 6-months gluten challenge. Five patients with seronegative CD (25%) experienced the occurrence of autoimmune diseases during a median follow-up of 133\u2005months (range 72\u2013192).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with seronegative CD did not display a specific profile. They benefitted from GFD as patients with seropositive CD. Waiting for more sensitive serological markers, the diagnosis of seronegative CD remains a diagnosis of exclusion.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgast-2017-000159","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T20:30:30Z","timestamp":1500323430000},"page":"e000159","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet"],"prefix":"10.1136","volume":"4","author":[{"given":"Maria Pina","family":"Dore","sequence":"first","affiliation":[{"name":"Internal Medicine Section, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"},{"name":"Baylor College of Medicine, Michael E. DeBakey VAMC, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Mario","family":"Pes","sequence":"additional","affiliation":[{"name":"Internal Medicine Section, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Dettori","sequence":"additional","affiliation":[{"name":"Internal Medicine Section, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[{"name":"Pathology Section, Department of Molecular and Translational Medicine, Spedali Civili and University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Manca","sequence":"additional","affiliation":[{"name":"Pathology Section, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Realdi","sequence":"additional","affiliation":[{"name":"Internal Medicine Section, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"2025073012520545000_4.1.e000159.1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24055"},{"key":"2025073012520545000_4.1.e000159.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.003"},{"key":"2025073012520545000_4.1.e000159.3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0016-5085(93)90912-V","article-title":"HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis","volume":"105","author":"Sollid","year":"1993","journal-title":"Gastroenterology"},{"key":"2025073012520545000_4.1.e000159.4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0889-8553(21)00038-8","article-title":"Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components","volume":"21","author":"Kagnoff","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"2025073012520545000_4.1.e000159.5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/gast.2000.8521","article-title":"Current concepts of celiac disease pathogenesis","volume":"19","author":"Schuppan","year":"2000","journal-title":"Gastroenterology"},{"key":"2025073012520545000_4.1.e000159.6","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.79"},{"key":"2025073012520545000_4.1.e000159.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302196"},{"key":"2025073012520545000_4.1.e000159.8","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.10"},{"key":"2025073012520545000_4.1.e000159.9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-5-200709040-00003"},{"key":"2025073012520545000_4.1.e000159.10","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(95)90032-2"},{"key":"2025073012520545000_4.1.e000159.11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025073012520545000_4.1.e000159.12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/17474124.2015.1039990","article-title":"Identification of new cases of severe enteropathy has recently increased the spectrum of intestinal non-celiac villous atrophy","volume":"9","author":"Malamut","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2025073012520545000_4.1.e000159.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.03.021"},{"key":"2025073012520545000_4.1.e000159.14","unstructured":"Cavalli-Sforza LL , Menozzi P , Piazza A , et al . The history and geography of human genes. Princeton: Princeton University Press, 1994."},{"key":"2025073012520545000_4.1.e000159.15","first-page":"129","article-title":"Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms","volume":"10","author":"Pironti","year":"2010","journal-title":"Minerva Med"},{"key":"2025073012520545000_4.1.e000159.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.003"},{"key":"2025073012520545000_4.1.e000159.17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.20.2959"},{"key":"2025073012520545000_4.1.e000159.18","first-page":"99","article-title":"Mucosal histopathology in celiac disease: a rebuttal of Oberhuber's sub-division of Marsh III","volume":"8","author":"N Marsh","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2025073012520545000_4.1.e000159.19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.dld.2016.05.024","article-title":"Seronegative celiac disease: Shedding light on an obscure clinical entity","volume":"48","author":"Volta","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2025073012520545000_4.1.e000159.20","doi-asserted-by":"crossref","first-page":"e0133497","DOI":"10.1371\/journal.pone.0133497","article-title":"Antibodies against proinsulin and homologous MAP epitopes are detectable in Hashimoto's thyroiditis Sardinian patients, an additional link of association","volume":"10","author":"Niegowska","year":"2015","journal-title":"PLoS ONE"},{"key":"2025073012520545000_4.1.e000159.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032487"},{"key":"2025073012520545000_4.1.e000159.22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.028"},{"key":"2025073012520545000_4.1.e000159.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.012"},{"key":"2025073012520545000_4.1.e000159.24","first-page":"110","article-title":"Seronegative celiac disease: where is the specific setting?","volume":"8","author":"Ierardi","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench."},{"key":"2025073012520545000_4.1.e000159.25","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181677067"},{"key":"2025073012520545000_4.1.e000159.26","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510023422"},{"key":"2025073012520545000_4.1.e000159.27","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.129668"},{"key":"2025073012520545000_4.1.e000159.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.03.028"},{"key":"2025073012520545000_4.1.e000159.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03744.x"},{"key":"2025073012520545000_4.1.e000159.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)03062-6"},{"key":"2025073012520545000_4.1.e000159.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.983_f.x"},{"key":"2025073012520545000_4.1.e000159.32","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000026296.02308.00"},{"key":"2025073012520545000_4.1.e000159.33","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005589202529"},{"key":"2025073012520545000_4.1.e000159.34","first-page":"276","article-title":"Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies","volume":"33","author":"Ashabani","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025073012520545000_4.1.e000159.35","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.45"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2017-000159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:52:13Z","timestamp":1753905133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2017-000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,7,17]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjgast-2017-000159"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2017-000159","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}